Targeting Inflammation Through a Physical Active Lifestyle and Pharmaceuticals for the Treatment of Type 2 Diabetes
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Inflammation Through a Physical Active Lifestyle and Pharmaceuticals for the Treatment of Type 2 Diabetes
Authors
Keywords
-
Journal
Current Diabetes Reports
Volume 15, Issue 10, Pages -
Publisher
Springer Nature
Online
2015-09-10
DOI
10.1007/s11892-015-0642-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pentoxifylline reduces the inflammatory process in diabetic rats: relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthase
- (2015) Francisca Adilfa de Oliveira Garcia et al. Journal of Inflammation-London
- Obesity and inflammation: reduced cytokine expression due to resveratrol in a human in vitro model of inflamed adipose tissue
- (2015) Ivana Zagotta et al. Frontiers in Pharmacology
- Effect of IL-6 on the insulin sensitivity in patients with type 2 diabetes
- (2014) N. M. Harder-Lauridsen et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The interleukin-1 receptor antagonist anakinra improves first-phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance
- (2014) P. C. M. van Poppel et al. DIABETES OBESITY & METABOLISM
- Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes
- (2014) Nathalie Esser et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes
- (2014) Matthew J. Butcher et al. DIABETOLOGIA
- Exercise training, but not resveratrol, improves metabolic and inflammatory status in skeletal muscle of aged men
- (2014) Jesper Olesen et al. JOURNAL OF PHYSIOLOGY-LONDON
- Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin
- (2014) Jan Mauer et al. NATURE IMMUNOLOGY
- Targeting inflammation in the treatment of type 2 diabetes: time to start
- (2014) Marc Y. Donath NATURE REVIEWS DRUG DISCOVERY
- Exercise as an anti-inflammatory therapy for rheumatic diseases—myokine regulation
- (2014) Fabiana B. Benatti et al. Nature Reviews Rheumatology
- Salicylate (Salsalate) in Patients With Type 2 Diabetes
- (2013) Allison B. Goldfine ANNALS OF INTERNAL MEDICINE
- Resident Macrophages Mediate Islet Amyloid Polypeptide–Induced Islet IL-1β Production and β-Cell Dysfunction
- (2013) Clara Y. Westwell-Roper et al. DIABETES
- Impact of interleukin-1β antibody (canakinumab) on glycaemic indicators in patients with type 2 diabetes mellitus: Results of secondary endpoints from a randomized, placebo-controlled trial
- (2013) J. Hensen et al. DIABETES & METABOLISM
- Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1 Antibody, in Patients With Type 2 Diabetes
- (2013) J. Sloan-Lancaster et al. DIABETES CARE
- Macrophages and islet inflammation in type 2 diabetes
- (2013) K. Eguchi et al. DIABETES OBESITY & METABOLISM
- Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus
- (2013) Andrew E. Hogan et al. DIABETOLOGIA
- Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model
- (2013) B. A. Omar et al. DIABETOLOGIA
- Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?
- (2013) Pura Muñoz-Cánoves et al. FEBS Journal
- Normal physical activity obliterates the deleterious effects of a high-caloric intake
- (2013) Rikke Krogh-Madsen et al. JOURNAL OF APPLIED PHYSIOLOGY
- Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men
- (2013) Lasse Gliemann et al. JOURNAL OF PHYSIOLOGY-LONDON
- Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
- (2013) Steven E Kahn et al. LANCET
- One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease
- (2013) João Tomé-Carneiro et al. PHARMACOLOGICAL RESEARCH
- High-Dose Resveratrol Supplementation in Obese Men: An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition
- (2012) M. M. Poulsen et al. DIABETES
- Altered Response of Skeletal Muscle to IL-6 in Type 2 Diabetic Patients
- (2012) L. Q. Jiang et al. DIABETES
- Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
- (2012) Hye-Mi Lee et al. DIABETES
- Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
- (2012) C. Cavelti-Weder et al. DIABETES CARE
- Does interference with the renin-angiotensin system protect against diabetes? Evidence and mechanisms
- (2012) N. J. van der Zijl et al. DIABETES OBESITY & METABOLISM
- Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial
- (2012) A. Rissanen et al. DIABETES OBESITY & METABOLISM
- Changes in insulin sensitivity precede changes in body composition during 14 days of step reduction combined with overfeeding in healthy young men
- (2012) Sine Haugaard Knudsen et al. JOURNAL OF APPLIED PHYSIOLOGY
- Sitagliptin Exerts an Antinflammatory Action
- (2012) Antoine Makdissi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Muscles, exercise and obesity: skeletal muscle as a secretory organ
- (2012) Bente K. Pedersen et al. Nature Reviews Endocrinology
- Satellite Cells Derived from Obese Humans with Type 2 Diabetes and Differentiated into Myocytes In Vitro Exhibit Abnormal Response to IL-6
- (2012) Camilla Scheele et al. PLoS One
- Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
- (2011) Paul M Ridker et al. AMERICAN HEART JOURNAL
- Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
- (2011) Silvie Timmers et al. Cell Metabolism
- Hyperglycemia Activates Caspase-1 and TXNIP-Mediated IL-1 Transcription in Human Adipose Tissue
- (2011) T. B. Koenen et al. DIABETES
- Telmisartan Improves Insulin Resistance and Modulates Adipose Tissue Macrophage Polarization in High-Fat-Fed Mice
- (2011) Shiho Fujisaka et al. ENDOCRINOLOGY
- Pioglitazone Compared to Glibenclamide on Lipid Profile and Inflammation Markers in Type 2 Diabetic Patients During an Oral Fat Load
- (2011) G. Derosa et al. HORMONE AND METABOLIC RESEARCH
- Treatment with Anakinra Improves Disposition Index But Not Insulin Sensitivity in Nondiabetic Subjects with the Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
- (2011) Edwin J. P. van Asseldonk et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Exenatide Exerts a Potent Antiinflammatory Effect
- (2011) Ajay Chaudhuri et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
- (2011) Helga Ellingsgaard et al. NATURE MEDICINE
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
- (2011) Bolormaa Vandanmagsar et al. NATURE MEDICINE
- Novel Anti-Inflammatory Effects of Repaglinide in Rodent Models of Inflammation
- (2011) David Tung et al. PHARMACOLOGY
- Is Interleukin-6 Receptor Blockade the Holy Grail for Inflammatory Diseases?
- (2010) M A Febbraio et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Accelerated Increase in Serum Interleukin-1 Receptor Antagonist Starts 6 Years Before Diagnosis of Type 2 Diabetes: Whitehall II Prospective Cohort Study
- (2010) M. Carstensen et al. DIABETES
- Anti-inflammatory action of exendin-4 in human islets is enhanced by phosphodiesterase inhibitors: potential therapeutic benefits in diabetic patients
- (2010) U. Pugazhenthi et al. DIABETOLOGIA
- Angiotensin blockade in diabetic patients decreases insulin resistance-associated low-grade inflammation
- (2010) Maria G. Pavlatou et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load
- (2010) Giuseppe Derosa et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- TNF-α Antagonism with Etanercept Decreases Glucose and Increases the Proportion of High Molecular Weight Adiponectin in Obese Subjects with Features of the Metabolic Syndrome
- (2010) Takara L. Stanley et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
- (2009) C. M. Larsen et al. DIABETES CARE
- Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
- (2009) Mohamed Lamkanfi et al. JOURNAL OF CELL BIOLOGY
- The diseasome of physical inactivity - and the role of myokines in muscle-fat cross talk
- (2009) Bente K. Pedersen JOURNAL OF PHYSIOLOGY-LONDON
- Interleukin-6 Is an Essential Regulator of Satellite Cell-Mediated Skeletal Muscle Hypertrophy
- (2008) Antonio L. Serrano et al. Cell Metabolism
- Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes
- (2008) Allison B. Goldfine et al. CTS-Clinical and Translational Science
- Human Endotoxemia as a Model of Systemic Inflammation
- (2008) A. Andreasen et al. CURRENT MEDICINAL CHEMISTRY
- Exendin-4 Protects -Cells From Interleukin-1 -Induced Apoptosis by Interfering With the c-Jun NH2-Terminal Kinase Pathway
- (2008) M. Ferdaoussi et al. DIABETES
- Elevated Levels of the Anti-Inflammatory Interleukin-1 Receptor Antagonist Precede the Onset of Type 2 Diabetes: The Whitehall II Study
- (2008) C. Herder et al. DIABETES CARE
- The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study
- (2008) J. Koska et al. DIABETOLOGIA
- Metabolic Responses to Reduced Daily Steps in Healthy Nonexercising Men
- (2008) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Increased Interleukin (IL)-1β Messenger Ribonucleic Acid Expression in β-Cells of Individuals with Type 2 Diabetes and Regulation of IL-1β in Human Islets by Glucose and Autostimulation
- (2008) Marianne Böni-Schnetzler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Statin synergizes with LPS to induce IL-1β release by THP-1 cells through activation of caspase-1
- (2008) Loes M. Kuijk et al. MOLECULAR IMMUNOLOGY
- The role of exercise and PGC1α in inflammation and chronic disease
- (2008) Christoph Handschin et al. NATURE
- General and Abdominal Adiposity and Risk of Death in Europe
- (2008) T. Pischon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
- (2008) Bente K. Pedersen et al. PHYSIOLOGICAL REVIEWS
- Interleukin-6 regulates pancreatic -cell mass expansion
- (2008) H. Ellingsgaard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now